Viiv Healthcare
Clinical trials sponsored by Viiv Healthcare, explained in plain language.
-
New Ultra-Long-Acting HIV shots could mean fewer doses for patients
Disease control Not yet recruitingThis study tests whether a new ultra-long-acting injectable HIV medication works as well as the current long-acting version. About 564 adults and teens with well-controlled HIV will receive either the ultra-long-acting or the standard long-acting shots. The goal is to see if the …
Phase: PHASE3 • Sponsor: ViiV Healthcare • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New HIV pill VH4770359 enters first human safety tests
Disease control Not yet recruitingThis early-stage study tests a new experimental HIV drug called VH4770359 in 214 healthy adults aged 18-55. The goal is to check its safety, side effects, and how the body processes it. Participants will take either the drug or a placebo, and some will also receive midazolam to s…
Phase: PHASE1 • Sponsor: ViiV Healthcare • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
HIV patients to keep receiving promising treatments in new study
Disease control Not yet recruitingThis study offers continued access to HIV medications (fostemsavir or dolutegravir/lamivudine) for 183 people who completed earlier ViiV Healthcare studies and are still benefiting. The goal is to provide treatment while collecting more safety information. Participants must have …
Phase: PHASE3 • Sponsor: ViiV Healthcare • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Scientists use radioactive tracer to follow new HIV Drug's path in the body
Knowledge-focused Not yet recruitingThis early-phase study will give 9 healthy adults a single dose of the experimental HIV drug VH4524184, plus a tiny radioactive version to track it. Researchers will measure how much of the drug gets into the blood, how it's broken down, and how it leaves the body through urine a…
Phase: PHASE1 • Sponsor: ViiV Healthcare • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC